Literature DB >> 25561796

Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.

Jian-Lin Wang1, Jing-Ping Yu1, Zhi-Qiang Sun1, Su-Ping Sun1.   

Abstract

AIM: To study the cancer stem cell population in esophageal cancer cell lines KYSE-150 and TE-1 and identify whether the resulting stem-like spheroid cells display cancer stem cells and radiation resistance characteristics.
METHODS: A serum-free medium (SFM) suspension was used to culture esophageal cancer stem cell lines and enrich the esophageal stem-like spheres. A reverse transcription polymerase chain reaction assay was used to detect stem cell gene expression in the spheroid cells. Radiosensitivity of stem-like spheres and parental cells were evaluated by clonogenic assays. Furthermore, different cells after different doses of irradiation were tested to evaluate the change in sphere formation, cell cycle and CD44(+)CD271(+) expression of tumor stem-like spheroid cells using flow cytometry before and after irradiation.
RESULTS: The cells were observed to generate an increased number of spheres in SFM with increasing cell passage. Radiation increased the rate of generation of stem-like spheres in both types of cells. The average survival fraction (SF2) of the cultured KYSE-150 compared with TE-1 stem-like spheres after 2 Gy of radiation was 0.81 ± 0.03 vs 0.87 ± 0.01 (P < 0.05), while the average SF2 of KYSE-150 compared with TE-1 parental cells was 0.69 ± 0.04 vs 0.80 ± 0.03, P < 0.05. In the esophageal parental cells, irradiation dose-dependently induced G2 arrest. Stem-like esophageal spheres were resistant to irradiation-induced G2 arrest without significant changes in the percentage population of irradiated stem-like cells. Under irradiation at 0, 4, and 8 Gy, the CD44(+)CD271(+) cell percentage for KYSE150 parental cells was 1.08% ± 0.03% vs 1.29% ± 0.07% vs 1.11% ± 0.09%, respectively; the CD44(+)CD271(+) cell percentage for TE1 parental cells was 1.16% ± 0.11% vs 0.97% ± 0.08% vs 1.45% ± 0.35%, respectively. The differences were not statistically significant. Under irradiation at 0, 4, and 8 Gy, the CD44(+)CD271(+) cell percentage for KYSE-150 stem-like spheres was 35.83% ± 1.23% vs 44.9% ± 1.67% vs 57.77% ± 1.88%, respectively; the CD44(+)CD271(+) cell percentage for TE1 stem-like spheres was 16.07% ± 0.91% vs 22.67% ± 1.12%, 16.07% ± 0.91% vs 33.27% ± 1.07%, respectively. The 4 and 8 Gy irradiated KYSE-150 and TE-1 stem-like spheres were compared with the 0 Gy irradiated group, and the differences were statistically significant (P < 0.05).
CONCLUSION: The KYSE-150 and TE-1 stem-like spheres are more radioresistant than their parental cells which may suggest that cancer stem cells are related to radioresistance.

Entities:  

Keywords:  Cell cycle; Cell spheres; Esophageal neoplasms; Neoplastic stem cell; Radiation resistance

Mesh:

Substances:

Year:  2014        PMID: 25561796      PMCID: PMC4277966          DOI: 10.3748/wjg.v20.i48.18296

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Novel signaling axis in CML-initiating cells.

Authors:  Cheng Cheng Zhang
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

Review 2.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.

Authors:  Young Chang Lim; Se-Yeong Oh; Yun Yi Cha; Sung-Hak Kim; Xun Jin; Hyunggee Kim
Journal:  Oral Oncol       Date:  2010-12-16       Impact factor: 5.337

5.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

6.  Identification and expansion of human colon-cancer-initiating cells.

Authors:  Lucia Ricci-Vitiani; Dario G Lombardi; Emanuela Pilozzi; Mauro Biffoni; Matilde Todaro; Cesare Peschle; Ruggero De Maria
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

Review 7.  Wnt signalling in implantation, decidualisation and placental differentiation--review.

Authors:  S Sonderegger; J Pollheimer; M Knöfler
Journal:  Placenta       Date:  2010-08-15       Impact factor: 3.481

8.  Identification of cancer stem cells in dog glioblastoma.

Authors:  G Stoica; G Lungu; H Martini-Stoica; S Waghela; J Levine; R Smith
Journal:  Vet Pathol       Date:  2009-01-27       Impact factor: 2.221

9.  Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.

Authors:  Daniel R Gomez; Margie A Hunt; Andrew Jackson; William P O'Meara; Elena N Bukanova; Michael J Zelefsky; Yoshiya Yamada; Kenneth E Rosenzweig
Journal:  Radiother Oncol       Date:  2009-11-16       Impact factor: 6.280

10.  Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro.

Authors:  Tomoyuki Okumura; Yutaka Shimada; Masayuki Imamura; Shigeru Yasumoto
Journal:  Oncogene       Date:  2003-06-26       Impact factor: 9.867

View more
  7 in total

Review 1.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

Review 2.  Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2017-09-14

Review 3.  Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer.

Authors:  Chenghui Zhou; Ningbo Fan; Fanyu Liu; Nan Fang; Patrick S Plum; René Thieme; Ines Gockel; Sascha Gromnitza; Axel M Hillmer; Seung-Hun Chon; Hans A Schlösser; Christiane J Bruns; Yue Zhao
Journal:  Cells       Date:  2020-06-17       Impact factor: 6.600

Review 4.  Cancer stem cells in esophageal squamous cell cancer.

Authors:  Qian Wu; Zhe Wu; Cuiyu Bao; Wenjing Li; Hui He; Yanling Sun; Zimin Chen; Hao Zhang; Zhifeng Ning
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

5.  LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7 via EZH2.

Authors:  Wenfang Cheng; Xiuling Shi; Mingqiang Lin; Qiwei Yao; Jiayu Ma; Jiancheng Li
Journal:  Front Cell Dev Biol       Date:  2020-11-24

6.  EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab.

Authors:  Lan Yu; Qing-Ming Guo; Yu Wang; Yan Xu; Li Liu; Xiao-Tao Zhang
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

Review 7.  Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine.

Authors:  Kelly A Whelan; Amanda B Muir; Hiroshi Nakagawa
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.